ClinicalTrials.gg
Sign In

Glucosephosphate Dehydrogenase Deficiency clinical trials

The registry lists 41 studies for Glucosephosphate Dehydrogenase Deficiency across more than 10 countries. 4 are recruiting or about to start. 16 of them are mainly about Glucosephosphate Dehydrogenase Deficiency (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-02.

Get an email when these change. Save the Glucosephosphate Dehydrogenase Deficiency studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
28
Status unknown
6
Recruiting
2
Not yet recruiting
2
Active, not recruiting
2
Terminated
1

Phase

Phase 4
6
Phase 2
6
Phase 1
3
Phase 3
3
Early Phase 1
1

Where

United States
14
Brazil
4
China
3
Thailand
3
Cambodia
2
Indonesia
2

Who runs them

PATH (6) · University of Thessaly (3) · Menzies School of Health Research (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · London School of Hygiene and Tropical Medicine (2) · University of Mississippi, Oxford (2) · Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (2) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

What is being tested here

Drugs under test in Glucosephosphate Dehydrogenase Deficiency studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Ascorbic Acid101
Ursodeoxycholic Acid101
Primaquine004
Tin mesoporphyrin002
Thioctic Acid002
Tafenoquine001
Dapsone Gel001
Chloroquine001
Aspirin001

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 2 Glucosephosphate Dehydrogenase Deficiency studies recruiting now, 1 (50%) set no upper age limit and 1 (50%) stop at 75 or younger. 1 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
AgeWomenMen
100 (0%)0 (0%)
181 (50%)1 (50%)
301 (50%)1 (50%)
401 (50%)1 (50%)
501 (50%)1 (50%)
651 (50%)1 (50%)
751 (50%)1 (50%)
851 (50%)1 (50%)

Across all 41 studies, recruiting or not: 51% stop at 75 or younger and 49% at 65; 56% take children; 0% are for women only and 5% for men only; 49% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 41 of 41. search them.